K. Giacomini, S. Huang, D. Tweedie, L. Benet, K. Brouwer et al., Membrane transporters in drug development, Nature Reviews Drug Discovery, vol.20, issue.3, pp.215-251, 2010.
DOI : 10.1038/nrd3028

C. Funk, The role of hepatic transporters in drug elimination, Expert Opinion on Drug Metabolism & Toxicology, vol.37, issue.4, pp.363-79, 2008.
DOI : 10.1080/00498250701570251

K. Kock and K. Brouwer, A Perspective on Efflux Transport Proteins in the Liver, Clinical Pharmacology & Therapeutics, vol.86, issue.1, pp.599-612, 2012.
DOI : 10.1038/clpt.2012.79

K. Yoshida, K. Maeda, and Y. Sugiyama, Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms, Annual Review of Pharmacology and Toxicology, vol.53, issue.1, pp.581-612, 2013.
DOI : 10.1146/annurev-pharmtox-011112-140309

J. Schuetz, P. Swaan, and D. Tweedie, The Role of Transporters in Toxicity and Disease, Drug Metabolism and Disposition, vol.42, issue.4, pp.541-546, 2014.
DOI : 10.1124/dmd.114.057539

T. Prueksaritanont, X. Chu, C. Gibson, D. Cui, K. Yee et al., Drug???Drug Interaction Studies: Regulatory Guidance and An Industry Perspective, The AAPS Journal, vol.15, issue.3, pp.629-674, 2013.
DOI : 10.1208/s12248-013-9470-x

O. Fardel, L. Payen, A. Courtois, L. Vernhet, and V. Lecureur, Regulation of biliary drug efflux pump expression by hormones and xenobiotics, Toxicology, vol.167, issue.1, pp.37-46, 2001.
DOI : 10.1016/S0300-483X(01)00456-5

L. Vee, M. Lecureur, V. Stieger, B. Fardel, and O. , Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-?? or Interleukin-6, Drug Metabolism and Disposition, vol.37, issue.3, pp.685-93, 2009.
DOI : 10.1124/dmd.108.023630

URL : https://hal.archives-ouvertes.fr/hal-00673249

C. Klaassen and L. Aleksunes, Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation, Pharmacological Reviews, vol.62, issue.1, pp.1-96, 2010.
DOI : 10.1124/pr.109.002014

M. Ruiz, A. Mottino, V. Catania, and M. Vore, Hormonal Regulation of Hepatic Drug Biotransformation and Transport Systems, Compr Physiol, vol.16, issue.Pt 1, pp.1721-1761, 2013.
DOI : 10.1002/cphy.c130018

V. Lecureur, A. Courtois, L. Payen, L. Verhnet, A. Guillouzo et al., Expression and regulation of hepatic drug and bile acid transporters, Toxicology, vol.153, issue.1-3, pp.203-222, 2000.
DOI : 10.1016/S0300-483X(00)00315-2

C. Klaassen and A. Slitt, Regulation of Hepatic Transporters by Xenobiotic Receptors, Current Drug Metabolism, vol.6, issue.4, pp.309-337, 2005.
DOI : 10.2174/1389200054633826

P. Chaudhary and I. Roninson, Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists, Oncol Res, vol.4, pp.281-90, 1992.

C. Stross, A. Helmer, K. Weissenberger, B. Gorg, V. Keitel et al., Protein kinase C induces endocytosis of the sodium taurocholate cotransporting polypeptide, AJP: Gastrointestinal and Liver Physiology, vol.299, issue.2, pp.320-328, 2010.
DOI : 10.1152/ajpgi.00180.2010

R. Kubitz, C. Huth, M. Schmitt, A. Horbach, G. Kullak-ublick et al., Protein kinase C???dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells, Hepatology, vol.34, issue.2, pp.340-50, 2001.
DOI : 10.1053/jhep.2001.25959

J. Powell, T. Farasyn, K. Kock, X. Meng, S. Pahwa et al., Novel Mechanism of Impaired Function of Organic Anion-Transporting Polypeptide 1B3 in Human Hepatocytes: Post-Translational Regulation of OATP1B3 by Protein Kinase C Activation, Drug Metabolism and Disposition, vol.42, issue.11, pp.1964-70, 2014.
DOI : 10.1124/dmd.114.056945

R. Kubitz, N. Saha, T. Kuhlkamp, S. Dutta, S. Dahl et al., Ca2+-dependent Protein Kinase C Isoforms Induce Cholestasis in Rat Liver, Journal of Biological Chemistry, vol.279, issue.11, pp.10323-10353, 2004.
DOI : 10.1074/jbc.M306242200

N. Kameyama, S. Arisawa, J. Ueyama, S. Kagota, K. Shinozuka et al., Increase in P-glycoprotein accompanied by activation of protein kinase C?? and NF-??B p65 in the livers of rats with streptozotocin-induced diabetes, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1782, issue.5, pp.355-60, 2008.
DOI : 10.1016/j.bbadis.2008.02.005

E. Ramboer, T. Vanhaecke, V. Rogiers, and M. Vinken, tools to study hepatic drug transporters, Drug Metabolism Reviews, vol.30, issue.2, pp.196-217, 2013.
DOI : 10.1091/mbc.E11-01-0047

L. Vee, M. Noel, G. Jouan, E. Stieger, B. Fardel et al., Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells, Toxicology in Vitro, vol.27, issue.6, pp.1979-86, 2013.
DOI : 10.1016/j.tiv.2013.07.003

URL : https://hal.archives-ouvertes.fr/hal-00866007

P. Gripon, S. Rumin, S. Urban, L. Seyec, J. Glaise et al., Nonlinear partial differential equations and applications: Infection of a human hepatoma cell line by hepatitis B virus, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15655-60, 2002.
DOI : 10.1073/pnas.232137699

E. Jigorel, L. Vee, M. Boursier-neyret, C. Bertrand, M. Fardel et al., FUNCTIONAL EXPRESSION OF SINUSOIDAL DRUG TRANSPORTERS IN PRIMARY HUMAN AND RAT HEPATOCYTES, Drug Metabolism and Disposition, vol.33, issue.10, pp.1418-1440, 2005.
DOI : 10.1124/dmd.105.004762

L. Vee, M. Jouan, E. Noel, G. Stieger, B. Fardel et al., Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes, Toxicology in Vitro, vol.29, issue.5, pp.938-984, 2015.
DOI : 10.1016/j.tiv.2015.03.019

URL : https://hal.archives-ouvertes.fr/hal-01141725

L. Vee, M. Jouan, E. Stieger, B. Lecureur, V. Fardel et al., Regulation of drug transporter expression by oncostatin M in human hepatocytes, Biochemical Pharmacology, vol.82, issue.3, pp.304-315, 2011.
DOI : 10.1016/j.bcp.2011.04.017

URL : https://hal.archives-ouvertes.fr/hal-00680752

L. Vee, M. Lecureur, V. Moreau, A. Stieger, B. Fardel et al., Differential Regulation of Drug Transporter Expression by Hepatocyte Growth Factor in Primary Human Hepatocytes, Drug Metabolism and Disposition, vol.37, issue.11, pp.2228-2263, 2009.
DOI : 10.1124/dmd.109.028035

URL : https://hal.archives-ouvertes.fr/hal-00673342

S. Oshevski, L. Bousse-kerdiles, M. Clay, D. Levashova, Z. Debili et al., Differential Expression of Protein Kinase C Isoform Transcripts in Human Hematopoietic Progenitors Undergoing Differentiation, Biochemical and Biophysical Research Communications, vol.263, issue.3, pp.603-612, 1999.
DOI : 10.1006/bbrc.1999.1425

O. Augustin, Reversible Ponceau staining as a loading control alternative to actin in Western blots, Analytical biochemistry, vol.401, pp.318-338, 2010.

J. Arts, J. Grimbergen, P. Bosma, H. Rahmsdorf, and T. Kooistra, Role of C-Jun and Proximal Phorbol 12-Myristate-13-Acetate-(PMA)-Responsive Elements in the Regulation of Basal and PMA-Stimulated Plasminogen-Activator Inhibitor-1 Gene Expression in HepG2, European Journal of Biochemistry, vol.22, issue.2, pp.393-402, 1996.
DOI : 10.1016/0092-8674(91)90241-P

P. Blackshear, The MARCKS family of cellular protein kinase C substrates, J Biol Chem, vol.268, pp.1501-1505, 1993.

R. Stravitz, Z. Vlahcevic, E. Gurley, and P. Hylemon, Repression of cholesterol 7 alphahydroxylase transcription by bile acids is mediated through protein kinase C in primary cultures of rat hepatocytes, J Lipid Res, vol.36, pp.1359-69, 1995.

M. Lebwohl, N. Swanson, L. Anderson, A. Melgaard, Z. Xu et al., Ingenol Mebutate Gel for Actinic Keratosis, New England Journal of Medicine, vol.366, issue.11, pp.1010-1019, 2012.
DOI : 10.1056/NEJMoa1111170

P. Hampson, H. Chahal, F. Khanim, R. Hayden, A. Mulder et al., PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC, Blood, vol.106, issue.4, pp.1362-1370, 2005.
DOI : 10.1182/blood-2004-10-4117

D. Toullec, P. Pianetti, H. Coste, P. Bellevergue, T. Grand-perret et al., The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C, J Biol Chem, vol.266, pp.15771-81, 1991.

E. Peterman, P. Taormina, M. Harvey, and L. Young, G?? 6983 Exerts Cardioprotective Effects in Myocardial Ischemia/Reperfusion, Journal of Cardiovascular Pharmacology, vol.43, issue.5, pp.645-56, 2004.
DOI : 10.1097/00005344-200405000-00006

H. He, A. Davidson, D. Wu, F. Marshall, L. Chung et al., Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells, The Prostate, vol.1, issue.10, pp.1119-1145, 2010.
DOI : 10.1002/pros.21146

P. Savagner, The epithelial-mesenchymal transition (EMT) phenomenon, Annals of Oncology, vol.21, issue.Supplement 7, 2010.
DOI : 10.1093/annonc/mdq292

URL : https://hal.archives-ouvertes.fr/inserm-00636091

A. Cervantes-arias, L. Pang, and D. Argyle, Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype, Veterinary and Comparative Oncology, vol.3, issue.3, pp.169-84, 2013.
DOI : 10.1111/j.1476-5829.2011.00313.x

H. Peinado, D. Olmeda, and C. A. Snail, Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?, Nature Reviews Cancer, vol.176, issue.6, pp.415-443, 2007.
DOI : 10.1038/nrc2131

T. Nagai, T. Arao, K. Furuta, K. Sakai, K. Kudo et al., Sorafenib Inhibits the Hepatocyte Growth Factor-Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma, Molecular Cancer Therapeutics, vol.10, issue.1, pp.169-77, 2011.
DOI : 10.1158/1535-7163.MCT-10-0544

A. Kaimori, J. Potter, J. Kaimori, C. Wang, E. Mezey et al., Transforming Growth Factor-beta1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro, Journal of Biological Chemistry, vol.282, issue.30, pp.22089-101, 2007.
DOI : 10.1074/jbc.M700998200

A. Kiselyuk, S. Lee, S. Farber-katz, M. Zhang, S. Athavankar et al., HNF4?? Antagonists Discovered by a High-Throughput Screen for Modulators of the Human Insulin Promoter, Chemistry & Biology, vol.19, issue.7, pp.806-824, 2012.
DOI : 10.1016/j.chembiol.2012.05.014

L. Santangelo, A. Marchetti, C. Cicchini, A. Conigliaro, B. Conti et al., The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4??, Hepatology, vol.51, issue.6, pp.2063-74, 2011.
DOI : 10.1002/hep.24280

URL : https://hal.archives-ouvertes.fr/pasteur-00980177

L. Vee, M. Jouan, E. Stieger, B. Fardel, and O. , Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes, European Journal of Pharmaceutical Sciences, vol.48, issue.4-5, pp.767-74, 2013.
DOI : 10.1016/j.ejps.2013.01.005

URL : https://hal.archives-ouvertes.fr/inserm-00804935

A. Zanetti, R. Affatato, F. Centritto, M. Fratelli, M. Kurosaki et al., -retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells, Journal of Biological Chemistry, vol.290, issue.29, pp.17690-709, 2015.
DOI : 10.1074/jbc.M115.638510

URL : https://hal.archives-ouvertes.fr/in2p3-00509098

S. Kermorgant, D. Zicha, and P. Parker, PKC controls HGF-dependent c-Met traffic, signalling and cell migration, The EMBO Journal, vol.21, issue.19, pp.3721-3755, 2004.
DOI : 10.1002/jcb.10358

M. Anwer, Role of protein kinase C isoforms in bile formation and cholestasis, Hepatology, vol.275, issue.4
DOI : 10.1002/hep.27088

M. Hong, W. Hong, C. Ni, J. Huang, and C. Zhou, Protein kinase C affects the internalization and recycling of organic anion transporting polypeptide 1B1, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1848, issue.10, pp.2022-2052, 2015.
DOI : 10.1016/j.bbamem.2015.05.011

C. Schonhoff, C. Webster, and M. Anwer, Taurolithocholate-induced MRP2 retrieval involves MARCKS phosphorylation by protein kinase C?? in HUH-NTCP Cells, Hepatology, vol.78, issue.1, pp.284-92, 2013.
DOI : 10.1002/hep.26333

K. Kock, A. Koenen, B. Giese, M. Fraunholz, K. May et al., Rapid Modulation of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1, SLCO2B1) Function by Protein Kinase C-mediated Internalization, Journal of Biological Chemistry, vol.285, issue.15, pp.11336-11383, 2010.
DOI : 10.1074/jbc.M109.056457

Z. Sarwar, F. Annaba, A. Dwivedi, S. Saksena, R. Gill et al., Modulation of ileal apical Na+-dependent bile acid transporter ASBT by protein kinase C, AJP: Gastrointestinal and Liver Physiology, vol.297, issue.3, p.1, 2009.
DOI : 10.1152/ajpgi.00052.2009

S. Antherieu, C. Chesne, R. Li, C. Guguen-guillouzo, and A. Guillouzo, Optimization of the HepaRG cell model for drug metabolism and toxicity studies, Toxicology in Vitro, vol.26, issue.8, pp.1278-85, 2012.
DOI : 10.1016/j.tiv.2012.05.008

URL : https://hal.archives-ouvertes.fr/hal-00866017

T. Andersson, K. Kanebratt, and J. Kenna, tool for understanding drug metabolism and toxicology in human, Expert Opinion on Drug Metabolism & Toxicology, vol.51, issue.5, pp.909-929, 2012.
DOI : 10.1016/j.transproceed.2010.08.064

L. Saraiva, P. Fresco, E. Pinto, and J. Goncalves, Characterization of phorbol esters activity on individual mammalian protein kinase C isoforms, using the yeast phenotypic assay, European Journal of Pharmacology, vol.491, issue.2-3, pp.101-111, 2004.
DOI : 10.1016/j.ejphar.2004.03.035

D. Burns and R. Bell, Protein kinase C contains two phorbol ester binding domains, J Biol Chem, vol.266, pp.18330-18338, 1991.

M. Gschwendt, H. Muller, K. Kielbassa, R. Zang, W. Kittstein et al., Rottlerin, a Novel Protein Kinase Inhibitor, Biochemical and Biophysical Research Communications, vol.199, issue.1, pp.93-101, 1994.
DOI : 10.1006/bbrc.1994.1199

L. Yin, N. Bennani-baiti, and C. Powell, Phorbol Ester-induced Apoptosis of C4-2 Cells Requires Both a Unique and a Redundant Protein Kinase C Signaling Pathway, Journal of Biological Chemistry, vol.280, issue.7, pp.5533-5574, 2005.
DOI : 10.1074/jbc.M405266200

G. Barriere, P. Fici, G. Gallerani, F. Fabbri, and M. Rigaud, Epithelial Mesenchymal Transition: a double-edged sword, Clinical and Translational Medicine, vol.11, issue.1, pp.15-0055, 2015.
DOI : 10.1186/s40169-015-0055-4

S. Choi and A. Diehl, Epithelial-to-mesenchymal transitions in the liver, Hepatology, vol.135, issue.Suppl 1, pp.2007-2020, 2009.
DOI : 10.1002/hep.23196

N. Zucchini-pascal, L. Peyre, and R. Rahmani, Crosstalk between Beta-Catenin and Snail in the Induction of Epithelial to Mesenchymal Transition in Hepatocarcinoma: Role of the ERK1/2 Pathway, International Journal of Molecular Sciences, vol.14, issue.10, pp.20768-92, 2013.
DOI : 10.3390/ijms141020768

D. Mochly-rosen, K. Das, and K. Grimes, Protein kinase C, an elusive therapeutic target?, Nature Reviews Drug Discovery, vol.277, issue.12, pp.937-57, 2012.
DOI : 10.1038/nrd3871